EMA Authorised: Macitentan AccordPharma (macitentan) — Accord Healthcare

View source ↗

Summary

Macitentan AccordPharma has been authorized for use, with the therapeutic areas listed as hypertension and pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Pulmonary Arterial Hypertension

Drugs mentioned

• Macitentan AccordPharma (macitentan)

Snippet

Status: Authorised. Therapeutic area: Hypertension, Pulmonary. MAH: Accord Healthcare. Decision date: 23/07/2026